RecruitingNCT05776147
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
Sponsor
Latin American Cooperative Oncology Group
Enrollment
400 participants
Start Date
Nov 9, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- Women over 18 years old;
- Diagnosis of breast cancer of any molecular subtype;
- Undergoing extreme hypofractionated radiotherapy (5 x 5.2Gy) postoperatively;
- Treated from December/2019 onward;
- With clinical and treatment data available in medical records.
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05776147
Related Trials
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT0488992459 locations
Curatively Intended Thoracic Reirradiation
NCT069500731 location
SMC Radiation Oncology Breast Cancer Cohort Study
NCT057757571 location
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
NCT063119811 location
Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
NCT066481481 location